CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists.
about
Cutaneous Leishmaniasis Vaccination: A Matter of QualityAdjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunityBlimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis.A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasisCross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal DomainsDisease severity in patients infected with Leishmania mexicana relates to IL-1β.Regulatory IgDhi B Cells Suppress T Cell Function via IL-10 and PD-L1 during Progressive Visceral Leishmaniasis.Polyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adults.Impairment of T cell function in parasitic infections.Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy.Differential Regulation of the Immune Response in the Spleen and Liver of Mice Infected with Leishmania donovani.In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccineCD8(+) T cells in leishmania infections: friends or foes?CXCL10 is critical for the generation of protective CD8 T cell response induced by antigen pulsed CpG-ODN activated dendritic cells.HIV-specific CD8⁺ T cells and HIV eradicationCase report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana.CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasisLeishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion.Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function.Toll-Like Receptor 2 Is Required for Inflammatory Process Development during Leishmania infantum Infection.AAV8 induces tolerance in murine muscle as a result of poor APC transduction, T cell exhaustion, and minimal MHCI upregulation on target cells.Toll-like receptors in leishmania infections: guardians or promoters?T cell exhaustion in protozoan disease.Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.Dysfunctional adaptive immunity during parasitic infectionsThe Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis.Immune checkpoints and their inhibition in cancer and infectious diseases.Leishmania major large RAB GTPase is highly immunogenic in individuals immune to cutaneous and visceral leishmaniasis.Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.Analysis of iron superoxide dismutase-encoding DNA vaccine on the evolution of the Leishmania amazonensis experimental infection.Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis.Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB/c Mice.Nivolumab Enhances In Vitro Effector Functions of PD-1+ T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner.CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection.How to master the host immune system? Leishmania parasites have the solutions!PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis.
P2860
Q26752521-0E6CA342-1240-4960-B952-BE16813AC155Q26782131-5443565B-1AD4-4ABC-A296-7557C061F291Q30276224-403C54DF-2DD1-483A-A212-4F896E4E7E61Q30385378-5C0CABF6-19EB-4C56-BB66-38F6490CAA83Q33559668-E505622A-D895-440F-89B0-CBEE7F9DA7FCQ33579979-CF0C4A80-8E3F-4B04-9F1F-59701C942F04Q34282214-B3AEB005-D565-4EA8-9D55-44700E8A53D1Q34522093-BAFB4C61-7E7D-4C48-80DF-7912B32CF9FAQ35071204-401E3C85-FE94-4C46-B809-7830823EFE63Q35097790-97E413A8-A423-4C95-94D0-02B8CE0A5F7BQ35098224-75166706-6089-4CFE-A9BD-374C6EE5A0CEQ35115431-86FF8DC4-5F2B-4EC5-8369-A8EE51C4575EQ35127522-DB4929A5-DEFD-4424-A8C0-6E95DAF948E2Q35198753-9566B45C-E24B-4FF5-A2C6-9010CCB7119CQ35326248-305E44E8-DF49-42D0-8E28-63F07BB6D1ACQ35927465-2DF3BA46-5E37-4040-9437-B3A86864ED80Q36381011-44EC4C1E-2450-44E1-A026-82A5FFD0A643Q36515071-59A2F73E-BE50-4C6F-A4E3-57C144B306ADQ36523002-2D7944F1-4D9B-4A19-B1C4-E5E9076F35F2Q36886086-664107CE-461D-481C-8B8F-BC4442F81F62Q36913750-05E8ADF5-3FFB-4B6F-9E8F-34DE43DFDFDDQ37080079-D9A6D4F0-85C3-4CA6-9559-15445F2024B7Q37494790-33DC5CF8-3A27-4D03-8E01-099C4587D244Q37660791-6FE33126-69FF-40CB-9D1D-B776BA99C431Q37690491-2EB8C368-A067-4A4A-B131-11259B96EC63Q38004493-14A2D852-7D01-4042-A944-A14E0E56B03FQ38029470-11EFBC54-353A-4DE3-8DE1-4D2CF7343B33Q38051035-EACC5189-9096-4B05-997E-AA94A8743DFEQ38212667-E514C8F6-2C14-48F6-B30A-5B8C0A5D718FQ38261036-575CA2CA-EA70-4BD6-BE2B-F6059D0ACB5EQ38845026-7F56D7C6-4897-4F48-96C4-B8D291E616CDQ40239822-C3B2310A-084C-4C87-997A-3B33DEE3CDECQ40765719-D238E043-6271-4FFF-B8A8-057D6F3E216CQ41187341-384E001E-81B0-41FA-A70D-02EA4DE0A297Q46080853-36C56583-0D2D-41D1-A236-7766AFE93C58Q47098436-98C97DEB-3B29-4292-A353-F742E987071BQ47194075-68D89FA5-76B2-4E7C-9D47-6BAAE567F483Q49562362-76754A37-D44D-4F58-882C-C6F05D26343FQ52401290-BE6A7264-3E04-4CFB-8E3F-1BD04A0C789AQ54943471-72A26FB5-CCBF-4EE5-92FD-5A63D1549B63
P2860
CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CD8 cells of patients with dif ...... d, in vitro, by TLR2 agonists.
@ast
CD8 cells of patients with dif ...... d, in vitro, by TLR2 agonists.
@en
type
label
CD8 cells of patients with dif ...... d, in vitro, by TLR2 agonists.
@ast
CD8 cells of patients with dif ...... d, in vitro, by TLR2 agonists.
@en
prefLabel
CD8 cells of patients with dif ...... d, in vitro, by TLR2 agonists.
@ast
CD8 cells of patients with dif ...... d, in vitro, by TLR2 agonists.
@en
P2093
P2860
P1476
CD8 cells of patients with dif ...... ed, in vitro, by TLR2 agonists
@en
P2093
Adriana Ruiz-Remigio
Alejandro Zentella
Georgina Carrada
Ingeborg Becker
Norma Salaiza-Suazo
Sofía Escoto
Yvonne Rosenstein
P2860
P356
10.1371/JOURNAL.PNTD.0000871
P407
P5008
P577
2010-11-02T00:00:00Z